138 related articles for article (PubMed ID: 36870645)
1. zwitterionic Pluronic analog-coated PLGA nanoparticles for oral insulin delivery.
Liu K; Chen Y; Yang Z; Jin J
Int J Biol Macromol; 2023 May; 236():123870. PubMed ID: 36870645
[TBL] [Abstract][Full Text] [Related]
2. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
3. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
[TBL] [Abstract][Full Text] [Related]
4. Novel PLGA-based nanoparticles for the oral delivery of insulin.
Malathi S; Nandhakumar P; Pandiyan V; Webster TJ; Balasubramanian S
Int J Nanomedicine; 2015; 10():2207-18. PubMed ID: 25848248
[TBL] [Abstract][Full Text] [Related]
5. Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin delivery.
Asal HA; Shoueir KR; El-Hagrasy MA; Toson EA
Int J Biol Macromol; 2022 Jun; 209(Pt B):2188-2196. PubMed ID: 35504421
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption.
Song Y; Shi Y; Zhang L; Hu H; Zhang C; Yin M; Chu L; Yan X; Zhao M; Zhang X; Mu H; Sun K
Mol Pharm; 2019 Feb; 16(2):518-532. PubMed ID: 30601014
[TBL] [Abstract][Full Text] [Related]
7. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles with surface features of dendritic oligopeptides as potential oral drug delivery systems.
Bai Y; Zhou R; Wu L; Zheng Y; Liu X; Wu R; Li X; Huang Y
J Mater Chem B; 2020 Apr; 8(13):2636-2649. PubMed ID: 32129375
[TBL] [Abstract][Full Text] [Related]
10. Utilization of PLGA nanoparticles in yeast cell wall particle system for oral targeted delivery of exenatide to improve its hypoglycemic efficacy.
Ren T; Zheng X; Bai R; Yang Y; Jian L
Int J Pharm; 2021 May; 601():120583. PubMed ID: 33839225
[TBL] [Abstract][Full Text] [Related]
11. Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery.
Wu J; Zheng Y; Liu M; Shan W; Zhang Z; Huang Y
ACS Appl Mater Interfaces; 2018 Mar; 10(12):9916-9928. PubMed ID: 29504398
[TBL] [Abstract][Full Text] [Related]
12. Progress in oral insulin delivery by PLGA nanoparticles for the management of diabetes.
Pang H; Huang X; Xu ZP; Chen C; Han FY
Drug Discov Today; 2023 Jan; 28(1):103393. PubMed ID: 36208724
[TBL] [Abstract][Full Text] [Related]
13. Insulin-loaded PLGA nanoparticles for oral administration: an in vitro physico-chemical characterization.
Santander-Ortega MJ; Bastos-González D; Ortega-Vinuesa JL; Alonso MJ
J Biomed Nanotechnol; 2009 Feb; 5(1):45-53. PubMed ID: 20055105
[TBL] [Abstract][Full Text] [Related]
14. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations.
Ahmad N; Alam MA; Ahmad R; Umar S; Jalees Ahmad F
J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288
[TBL] [Abstract][Full Text] [Related]
15. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS
Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
[TBL] [Abstract][Full Text] [Related]
16. Lipid-PLGA hybrid nanoparticles of paclitaxel: Preparation, characterization, in vitro and in vivo evaluation.
Godara S; Lather V; Kirthanashri SV; Awasthi R; Pandita D
Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110576. PubMed ID: 32228957
[TBL] [Abstract][Full Text] [Related]
17. Improved oral delivery of insulin by PLGA nanoparticles coated with 5
Wang W; Yu C; Zhang F; Li Y; Zhang B; Huang J; Zhang Z; Jin L
Biomed Mater; 2021 Oct; 16(6):. PubMed ID: 34571498
[TBL] [Abstract][Full Text] [Related]
18. In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles.
Reix N; Parat A; Seyfritz E; Van der Werf R; Epure V; Ebel N; Danicher L; Marchioni E; Jeandidier N; Pinget M; Frère Y; Sigrist S
Int J Pharm; 2012 Nov; 437(1-2):213-20. PubMed ID: 22940208
[TBL] [Abstract][Full Text] [Related]
19. Targeted folate-conjugated pluronic P85/poly(lactide-co-glycolide) polymersome for the oral delivery of insulin.
Xie S; Gong YC; Xiong XY; Li ZL; Luo YY; Li YP
Nanomedicine (Lond); 2018 Oct; 13(19):2527-2544. PubMed ID: 30338724
[TBL] [Abstract][Full Text] [Related]
20. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
